Interim CEO Alleges Garg 'Found Guilty of Breach of Fiduciary Duty' in Proxy Fight
BETR is trading near its 52-week low of $10.24 (2.1% above the low).
Summary
Interim CEO Daniel Lewis publicly stated that founder Vishal Garg was 'previously found guilty of a breach of fiduciary duty' and that the entire Board except Garg believes he is not CEO 'for very, very good reasons,' escalating the public messaging in the ongoing proxy fight.
Key Events · Corporate Governance and Compliance · BETR
-
Interim CEO Alleges Garg Breach of Fiduciary Duty
Daniel Lewis stated on X that Vishal Garg 'has been previously found guilty of a breach of fiduciary duty' and that the entire Board except Garg believes he is not CEO 'for very, very good reasons.'
-
New Disclosure on Past Partner Consent Violations
Lewis revealed that Better previously made statements without partner consent and received 'nasty letters from lawyers alleging breach of contract and even threatening termination' — a new admission about past governance practices.
-
Wholesale Channel Launch Reframed
Lewis clarified the company is launching a wholesale distribution channel rather than TinmanGo as a standalone product, stating Better had 'TEN YEARS and never entered the most obvious channel.'
-
Proxy Fight Escalation Continues
This is the 23rd DEFA14A filing in 90 days amid a failed consent solicitation, a poison pill challenge, and a Delaware lawsuit, with the stock trading near its 52-week low of $10.24.
Analysis · BETR · Finance
In the ongoing proxy battle with founder Vishal Garg, interim CEO Daniel Lewis delivered his most direct public statements yet. He asserted that Garg 'has been previously found guilty of a breach of fiduciary duty' and that the entire Board except Garg believes he is not CEO 'for very, very good reasons.' Lewis also disclosed that Better previously made partner statements without consent and received legal threats alleging breach of contract — a new admission about past governance practices. These statements come amid a 90-day period that has already seen 22 DEFA14A filings, a failed consent solicitation, a poison pill challenge, and a Delaware lawsuit, with the stock trading near its 52-week low of $10.24.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.6% of the 1609 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BETR was trading at $10.45 on NASDAQ in the Finance sector, with a market capitalization of approximately $198.7M. The 52-week trading range was $10.24 to $92.69. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.